Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Melanoma 47 Carcinoma, Non-Small-Cell Lung 16 Colorectal Neoplasms 14 Lung Neoplasms 11 Neoplasm Metastasis 10 Pancreatic Neoplasms 9 Brain Neoplasms 9 Neoplasms 8 Triple Negative Breast Neoplasms 6 Skin Neoplasms 5 Colonic Neoplasms 5 Rectal Neoplasms 4 Ovarian Neoplasms 4 Uveal Melanoma 3 Thyroid Neoplasms 3 Multiple Myeloma 3 Hematologic Neoplasms 3 Glioma 3 Gastrointestinal Stromal Tumors 3 Breast Neoplasms 3 Biliary Tract Neoplasms 3 Solid Tumor 2 Skin Diseases 2 Recurrence 2 Neurofibromatosis 1 2 Lymphoma 2 Leukemia, Hairy Cell 2 Hereditary Sensory and Autonomic Neuropathies 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2

Interventions

Temozolomide 131 Radiotherapy 87 Bevacizumab 43 Radiation 31 Carmustine 29 Magnetic Resonance Spectroscopy 22 Irinotecan 22 Erlotinib Hydrochloride 22 Chemotherapy, Adjuvant 20 Surgical Procedures, Operative 15 O(6)-benzylguanine 15 Carboplatin 14 Radiotherapy, Intensity-Modulated 13 Radiotherapy, Conformal 13 sargramostim 12 Sirolimus 9 Imatinib Mesylate 9 Filgrastim 9 Drug Therapy 9 temsirolimus 8 Thalidomide 8 Sorafenib 8 Radiosurgery 8 pembrolizumab 7 motexafin gadolinium 7 aldesleukin 7 Vorinostat 7 Procarbazine 7 Gene Expression Profiling 7 Gefitinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Gliosarcoma × binimetinib × Clear all

NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡